Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Dec 22;375(25):2499-500.
doi: 10.1056/NEJMc1613270.

Andexanet Alfa for Factor Xa Inhibitor Reversal

Affiliations
Comment

Andexanet Alfa for Factor Xa Inhibitor Reversal

Stuart J Connolly et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.
    Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M; ANNEXA-4 Investigators. Connolly SJ, et al. N Engl J Med. 2016 Sep 22;375(12):1131-41. doi: 10.1056/NEJMoa1607887. Epub 2016 Aug 30. N Engl J Med. 2016. PMID: 27573206 Free PMC article. Clinical Trial.
  • Andexanet Alfa for Factor Xa Inhibitor Reversal.
    Wang JJ, Gosselin S, Villeneuve E. Wang JJ, et al. N Engl J Med. 2016 Dec 22;375(25):2498. doi: 10.1056/NEJMc1613270. N Engl J Med. 2016. PMID: 28009494 No abstract available.
  • Andexanet Alfa for Factor Xa Inhibitor Reversal.
    Birocchi S, Fiorelli EM, Podda GM. Birocchi S, et al. N Engl J Med. 2016 Dec 22;375(25):2498-9. doi: 10.1056/NEJMc1613270. N Engl J Med. 2016. PMID: 28009495 No abstract available.

MeSH terms

Substances

LinkOut - more resources